Depo-Provera Lawsuit 2026: Meningioma Brain Tumor Claims Against Pfizer
The Depo-Provera lawsuit claims that Pfizer failed to adequately warn patients that long-term use of the Depo-Provera birth control injection significantly increases the risk of developing meningioma — a potentially life-altering brain tumor. Scientific research published in peer-reviewed journals confirms a dramatically elevated meningioma risk associated with prolonged Depo-Provera use. Women who received Depo-Provera injections for one or more years and were subsequently diagnosed with meningioma may be entitled to significant Depo-Provera lawsuit settlement compensation.
Estimate your potential Depo-Provera lawsuit compensation with our free settlement calculator.
The Science: How Depo-Provera Causes Meningioma
Depo-Provera (medroxyprogesterone acetate) is a synthetic progestin contraceptive injected every three months. Scientific research, including a landmark 2024 study published in the British Medical Journal, found that women who used high-dose progestins like Depo-Provera for extended periods had a 5.6 times greater risk of developing intracranial meningioma compared to non-users. The risk increases with duration of use and persists even after stopping the injections.
According to FDA safety communications, a Black Box Warning — the FDA’s most serious warning level — was added to Depo-Provera’s prescribing information acknowledging the meningioma risk. The Black Box Warning states that prolonged use of Depo-Provera may result in a significant loss of bone mineral density AND the risk of developing meningioma.
Depo-Provera lawsuit plaintiffs allege that Pfizer knew about the meningioma risk for years before the FDA required the Black Box Warning and failed to adequately disclose this danger to prescribing physicians and patients.
What Is Meningioma?
Meningioma is a tumor that develops in the meninges — the three layers of protective membranes surrounding the brain and spinal cord. Key facts about meningioma:
- Most are benign: Approximately 90% of meningiomas are classified as benign (non-cancerous), but “benign” does not mean harmless
- Dangerous location: Even benign meningiomas can be life-threatening and permanently disabling because they press on the brain, cranial nerves, or spinal cord
- Serious symptoms: Meningioma causes headaches, vision changes, hearing loss, seizures, memory impairment, personality changes, and weakness
- Difficult treatment: Meningioma treatment typically requires brain surgery (craniotomy) and/or radiation therapy, both of which carry significant risks
- Recurrence risk: Meningioma can recur after surgery, sometimes requiring multiple procedures over a lifetime
- Permanent effects: Many meningioma patients experience permanent neurological deficits even after successful treatment
Depo-Provera Lawsuit Settlement Amounts 2026
Depo-Provera lawsuit settlement estimates range from $100,000 to over $1,500,000 per plaintiff. The key factors determining settlement value in a Depo-Provera meningioma lawsuit include:
- Highest value cases: Brain surgery required (craniotomy), permanent neurological deficits, young women with long remaining life expectancy, multiple meningiomas, or recurrent tumors requiring repeated surgeries
- Moderate value cases: Radiation therapy required without surgery, significant symptoms managed with ongoing medication, meaningful impact on daily activities and employment
- Base value cases: Meningioma diagnosed and monitored without immediate treatment (watch-and-wait protocol), some symptoms but limited functional impairment
Cases involving large meningiomas in eloquent brain regions (areas controlling speech, movement, or vision), women who had to stop working, or young mothers with dependent children are expected to command the highest Depo-Provera settlement amounts.
Who Qualifies for a Depo-Provera Lawsuit?
- You received Depo-Provera (medroxyprogesterone acetate) injections for a cumulative period of 12 months or more
- You were subsequently diagnosed with meningioma (intracranial or spinal meningioma)
- Your meningioma required treatment (surgery, radiation, medication) OR is being monitored and affects your quality of life
- Your Depo-Provera use preceded your meningioma diagnosis
- You are within the applicable statute of limitations for filing a Depo-Provera lawsuit (typically 2-4 years from diagnosis, varying by state)
Depo-Provera MDL Status & Litigation Timeline 2026
Depo-Provera meningioma lawsuits have been consolidated in a federal Multi-District Litigation (MDL) in the Southern District of New York. Key developments:
- Thousands of women have filed Depo-Provera lawsuits against Pfizer
- MDL discovery is ongoing, with document production from Pfizer revealing internal communications about meningioma risk
- Bellwether trials are expected to begin in 2025-2026 to establish settlement frameworks
- Pfizer has not yet agreed to a global settlement program — individual Depo-Provera cases are being evaluated
- New Depo-Provera lawsuits are actively being filed and accepted into the MDL
Filing your Depo-Provera lawsuit promptly is critical — both to protect your statute of limitations rights and to ensure you benefit from early bellwether trial developments that will shape overall Depo-Provera settlement values.
The Depo-Provera Lawsuit Filing Process
- Free Case Evaluation: A Depo-Provera lawsuit attorney reviews your Depo-Provera injection history and meningioma diagnosis to determine if you qualify
- Medical Record Gathering: Your attorney obtains your Depo-Provera prescription history, injection records, and meningioma diagnosis documentation
- Expert Review: Medical experts confirm the link between your Depo-Provera use and meningioma in your specific case
- Complaint Filed: Your attorney files your Depo-Provera lawsuit and transfers it to the federal MDL
- Discovery: Both sides exchange evidence, including Pfizer’s internal documents about meningioma risks
- Settlement Negotiation or Trial: Most Depo-Provera cases are expected to settle, with individual negotiations informed by bellwether trial outcomes
Related Drug Injury Lawsuits
- Ozempic lawsuit — gastroparesis claims against Novo Nordisk
- Talcum powder lawsuit — ovarian cancer claims against Johnson & Johnson
- Mesothelioma lawsuit — asbestos cancer claims
- All mass tort lawsuits we actively handle in 2026
Depo-Provera Lawsuit Frequently Asked Questions
What is Depo-Provera and who uses it?
Depo-Provera is a brand-name injectable contraceptive containing medroxyprogesterone acetate (a synthetic progestin). It is administered as an injection every three months. Depo-Provera is used by millions of women worldwide as a long-acting, highly effective contraceptive. It is particularly popular among women who prefer not to take daily pills and has been widely prescribed for decades since FDA approval in 1992.
How do I know if my meningioma was caused by Depo-Provera?
Establishing causation for your Depo-Provera lawsuit requires: documented Depo-Provera injection history (pharmacy records, medical records), meningioma diagnosis, and a timeline showing you used Depo-Provera before your meningioma developed. Medical experts in Depo-Provera litigation use this evidence to establish the link between your specific Depo-Provera use and your meningioma diagnosis. Your attorney will work with medical experts to build this connection.
Can I still take Depo-Provera while my lawsuit is pending?
If you have been diagnosed with meningioma, most physicians strongly recommend discontinuing Depo-Provera immediately, as progestins can stimulate meningioma growth. Speak with your doctor about alternative contraception immediately. You can still file and pursue your Depo-Provera lawsuit regardless of whether you have already stopped taking it.
How much is a Depo-Provera settlement worth?
Depo-Provera settlement estimates range from $100,000 for monitored meningiomas to over $1.5 million for cases requiring brain surgery with permanent neurological consequences. Women who required craniotomy (brain surgery), experienced significant neurological deficits, or are young with long life expectancy of impairment typically qualify for the highest Depo-Provera settlement amounts. An attorney can evaluate your specific case value.
Does my age matter for a Depo-Provera lawsuit?
Yes — younger women with meningioma generally have higher Depo-Provera lawsuit settlement values because they face a longer lifetime of potential impairment, treatment costs, and impact on earning capacity. However, women of all ages who developed meningioma from Depo-Provera may qualify for significant compensation regardless of their age at diagnosis.
What if I had Depo-Provera prescribed by a Planned Parenthood or a clinic?
Your Depo-Provera lawsuit is against Pfizer — the manufacturer of Depo-Provera — not necessarily against the healthcare provider who prescribed it. Your clinic records showing Depo-Provera injections are exactly the type of evidence your attorney needs to file your Depo-Provera lawsuit. Planned Parenthood, OB/GYN offices, and community health center records all qualify as evidence in Depo-Provera meningioma lawsuits.
